|
Sociodemographic characteristics of cases
|
|
|
|
N
|
%
|
|
Gender
|
|
|
| Female |
35 |
58.33% |
| Male |
25 |
41.67% |
|
Age
|
|
|
| Mean age |
66 (±14) |
|
|
Smoker
|
|
|
| No |
35 |
58.33% |
| Yes |
25 |
41.67% |
|
Smoking status
|
|
|
| Never smoked |
35 |
58.33% |
| Smoked in the past |
25 |
41.67% |
| Currently smokes |
0 |
0.00% |
|
Cigarettes a day
|
|
|
| 0 cigarettes a day |
35 |
58.33% |
| 1 to 4 cigarettes a day |
10 |
16.67% |
| 5 to 9 cigarettes a day |
8 |
13.33% |
| 10 or more cigarettes a day |
7 |
11.67% |
|
Years of smoking
|
|
|
| 0 years smoking |
35 |
58.33% |
| 1 to 9 years smoking |
5 |
8.33% |
| 10 to 29 years smoking |
14 |
23.33% |
| 30 or more years of smoking |
6 |
10.00% |
|
Alcohol consumption
|
|
|
| No |
30 |
50.00% |
| Yes |
30 |
50.00% |
| Alcohol consumption status |
|
|
| Currently consuming alcohol |
18 |
30.00% |
| Consumed alcohol in the past |
11 |
18.33% |
| Never consumed alcohol |
31 |
51.67% |
|
Number of days a week consumes alcohol
|
|
|
| 0 days of the week |
31 |
51.67% |
| 1 to 2 days a week |
19 |
40.00% |
| 3 or more days a week |
5 |
8.33% |
|
Drinks a day
|
|
|
| 0 drinks a day |
31 |
51.67% |
| 1 to 4 drinks a day |
14 |
23.33% |
| 5 to 9 drinks a day |
8 |
13.33% |
| 10 or more drinks a day |
7 |
11.67% |
|
Clinical features of cases
|
|
|
|
N
|
%
|
|
Comorbidities
|
|
|
| Without comorbidities |
32 |
53.33% |
| With comorbidities |
28 |
46.67% |
|
Recurrent cases
|
|
|
| No recurrence |
39 |
65.00% |
| Local recurrence |
21 |
35.00% |
|
Death associated with disease
|
|
|
| 5-year survival |
47 |
78.33% |
| 5-year mortality |
13 |
21.67% |
|
Surgical resection of the initial primary
|
|
|
| No |
3 |
5.00% |
| Yes |
57 |
95.00% |
|
Surgical technique
|
|
|
| Hemiglossectomy |
12 |
20.00% |
| Hemiglossectomy plus neck dissection |
36 |
60.00% |
| Mandibulectomy plus radical neck dissection |
5 |
8.33% |
| Maxillofacial Surgery |
1 |
1.67% |
| Maxillofacial surgery plus neck dissection |
3 |
5.00% |
|
Radiotherapy
|
|
|
| No |
28 |
46.67% |
| Yes |
32 |
53.33% |
|
Chemotherapy
|
|
|
| No |
43 |
71.67% |
| Yes |
17 |
28.33% |
|
Chemotherapy regimen
|
|
|
| Cisplatin |
13 |
13 |
| Carboplatin, cetuximab, docetaxel |
1 |
1 |
| Carboplatin, paclitaxel |
1 |
1 |
| Cetuximab |
1 |
1 |
| Pembrolizumab |
1 |
1 |
| n/a |
43 |
43 |
|
Histopathological characteristics of cases
|
|
|
|
N
|
% |
|
Anatomical location cases
|
|
|
| C02.9. Tongue |
49 |
81.67% |
| C03.0 upper gingiva/ c03.1 lower gingiva |
3 |
5.00% |
| C04.9 floor of the mouth |
3 |
5.00% |
| C05.0 hard palate |
3 |
5.00% |
| C06.0 cheek mucosa |
2 |
3.33% |
|
Lymphovascular invasion cases
|
|
|
| n/a |
1 |
1.67% |
| No |
52 |
86.67% |
| Yes |
7 |
11.67% |
|
Perineural invasion cases
|
|
|
| n/a |
1 |
1.67% |
| No |
28 |
46.67% |
| Yes |
31 |
51.67% |
|
Histological grade
|
|
|
| Well differentiated |
29 |
48.33% |
| Moderately differentiated |
21 |
35.00% |
| Poorly differentiated |
10 |
16.67% |
|
Lymph node involvement
|
|
|
| n/a |
16 |
26.67% |
| Negative |
22 |
36.67% |
| Positive |
22 |
36.67% |
|
Clinical stage cases
|
|
|
| I |
20 |
33.33% |
| II |
8 |
13.33% |
| III |
9 |
15.00% |
| IVA |
20 |
33.33% |
| IVB |
2 |
3.33% |
| n/a |
1 |
1.67% |
